ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC) Options
Participant eaten grapefruit or grapefruit products within three days just before the primary dose of study drug.There may be bigger treatment load for contributors in this trial compared to their typical of treatment. Individuals will go to normal visits in the study at a medical center or clinic.In Segment C, individuals will obtain ABBV-744 and